Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $133,915 - $155,049
-1,384 Reduced 34.7%
2,605 $252,000
Q2 2022

Jul 19, 2022

SELL
$102.07 - $123.37 $107,990 - $130,525
-1,058 Reduced 20.96%
3,989 $433,000
Q1 2022

May 12, 2022

SELL
$114.02 - $139.04 $156,777 - $191,180
-1,375 Reduced 21.41%
5,047 $597,000
Q4 2021

Feb 07, 2022

SELL
$115.53 - $141.46 $57,880 - $70,871
-501 Reduced 7.24%
6,422 $904,000
Q3 2021

Nov 15, 2021

BUY
$116.66 - $129.06 $442,958 - $490,040
3,797 Added 121.47%
6,923 $818,000
Q2 2021

Aug 16, 2021

SELL
$105.79 - $124.53 $92,777 - $109,212
-877 Reduced 21.91%
3,126 $362,000
Q1 2021

Apr 30, 2021

BUY
$108.84 - $128.23 $4,788 - $5,642
44 Added 1.11%
4,003 $480,000
Q4 2020

Feb 05, 2021

SELL
$105.0 - $114.42 $27,300 - $29,749
-260 Reduced 6.16%
3,959 $434,000
Q3 2020

Nov 13, 2020

BUY
$91.64 - $111.29 $22,635 - $27,488
247 Added 6.22%
4,219 $459,000
Q2 2020

Aug 14, 2020

BUY
$76.57 - $98.0 $59,418 - $76,048
776 Added 24.28%
3,972 $363,000
Q1 2020

May 15, 2020

BUY
$62.82 - $91.86 $200,772 - $293,584
3,196 New
3,196 $252,000
Q4 2019

Feb 13, 2020

SELL
$78.51 - $87.4 $502,542 - $559,447
-6,401 Closed
0 $0
Q3 2019

Nov 08, 2019

BUY
$81.84 - $88.74 $38,955 - $42,240
476 Added 8.03%
6,401 $535,000
Q2 2019

Jul 29, 2019

BUY
$72.88 - $85.0 $47,080 - $54,910
646 Added 12.24%
5,925 $498,000
Q1 2019

May 13, 2019

BUY
$66.22 - $80.06 $3,840 - $4,643
58 Added 1.11%
5,279 $422,000
Q4 2018

Feb 12, 2019

BUY
$65.56 - $74.27 $20,585 - $23,320
314 Added 6.4%
5,221 $377,000
Q3 2018

Nov 09, 2018

BUY
$60.81 - $73.36 $298,394 - $359,977
4,907 New
4,907 $360,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $225B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Claraphi Advisory Network, LLC Portfolio

Follow Claraphi Advisory Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Claraphi Advisory Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Claraphi Advisory Network, LLC with notifications on news.